These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 577884)

  • 41. [Identification of chlorzoxazone metabolites in human urine (author's transl)].
    Twele R; Spiteller G
    Arzneimittelforschung; 1982; 32(7):759-63. PubMed ID: 6889877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [On the problem of side effects of clozapin (author's transl)].
    Vencovský E; Petrová E; Baudis P
    Cesk Psychiatr; 1976 Feb; 72(1):4-6. PubMed ID: 1269002
    [No Abstract]   [Full Text] [Related]  

  • 43. Microbial conversion of methyl- and methoxy- substituted derivatives of 5H-indolo[2,3-b]quinoline as a method of developing novel cytotoxic agents.
    Osiadacz J; Kaczmarek L; Opolski A; Wietrzyk J; Marcinkowska E; Biernacka K; Radzikowski C; Jon M; Peczyńska-Czoch W
    Anticancer Res; 1999; 19(4B):3333-42. PubMed ID: 10652630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolites of [(14)C]-5-(2-ethyl-2H-tetrazol-5-yl)-1-methyl-1,2,3, 6-tetrahydropyridine in mice, rats, dogs, and humans.
    Christensen EB; Andersen JB; Pedersen H; Jensen KG; Dalgaard L
    Drug Metab Dispos; 1999 Nov; 27(11):1341-9. PubMed ID: 10534320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Biotransformation and pharmacokinetics of AWD 26-06, 8-chloro-5,10-dihydro-5-[bis(2-hydroxyethyl)aminoacetyl]-11H-dibenzo[d, c][1,4]diazepin-11-one hydrochloride in the rat].
    Pfeifer S; Gedan A; Franke P; Klemm W; Morgenroth U
    Pharmazie; 1990 Jul; 45(8):603-7. PubMed ID: 2080209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of anticholinergics and clozapine on the activation of the striatal dopaminergic system in the rat by haloperidol. Neurochemical findings (author's transl)].
    Bürki HR; Sayers AC; Ruch W; Asper H
    Arzneimittelforschung; 1976; 26(6):1094-6. PubMed ID: 989385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolism and bioactivation of 3-methylindole by human liver microsomes.
    Yan Z; Easterwood LM; Maher N; Torres R; Huebert N; Yost GS
    Chem Res Toxicol; 2007 Jan; 20(1):140-8. PubMed ID: 17226936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo studied on the metabolism of dibenzo [c,f]-[1,2] diazepine.
    Frigerio A; Negrini P; Cappellini L; Rotilio D; De Pascale A; Rossi E
    Eur J Drug Metab Pharmacokinet; 1979; 4(2):67-74. PubMed ID: 488134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Syntheses of diazepine derivatives. (1). Syntheses of 2-chloro-11H-pyrimido-[4,5-b][1,4]benzodiazepin-6(5H)-one derivatives (author's transl)].
    Ina S; Morita K; Noguchi I
    Yakugaku Zasshi; 1978 Jan; 98(1):72-6. PubMed ID: 641705
    [No Abstract]   [Full Text] [Related]  

  • 50. Modified synthesis of 11-[14C]-clozapine.
    Matloubi H; Ghandi M; Zarrindast MR; Saemian N
    Appl Radiat Isot; 2001 Dec; 55(6):789-91. PubMed ID: 11761101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clozapine. Scientific update meeting. Montreux, Switzerland. October 31-November 1, 1988. Proceedings.
    Psychopharmacology (Berl); 1989; 99 Suppl():S1-125. PubMed ID: 2813661
    [No Abstract]   [Full Text] [Related]  

  • 52. Demethyl oxidative halogenation of diacyl dimethylsulfonium methylides.
    Fu D; Xi C; Xu J
    Org Biomol Chem; 2023 May; 21(19):3991-3996. PubMed ID: 37114954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance.
    Schaber G; Stevens I; Gaertner HJ; Dietz K; Breyer-Pfaff U
    Br J Clin Pharmacol; 1998 Nov; 46(5):453-9. PubMed ID: 9833598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CSF and serum concentrations of clozapine and its demethyl metabolite: a pilot study.
    Nordin C; Almé B; Bondesson U
    Psychopharmacology (Berl); 1995 Nov; 122(2):104-7. PubMed ID: 8848524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphisms.
    Dahl ML; Llerena A; Bondesson U; Lindström L; Bertilsson L
    Br J Clin Pharmacol; 1994 Jan; 37(1):71-4. PubMed ID: 8148222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytochrome P4502D6 genotype does not determine response to clozapine.
    Arranz MJ; Dawson E; Shaikh S; Sham P; Sharma T; Aitchison K; Crocq MA; Gill M; Kerwin R; Collier DA
    Br J Clin Pharmacol; 1995 Apr; 39(4):417-20. PubMed ID: 7640149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple-dose pharmacokinetics of clozapine in patients.
    Choc MG; Lehr RG; Hsuan F; Honigfeld G; Smith HT; Borison R; Volavka J
    Pharm Res; 1987 Oct; 4(5):402-5. PubMed ID: 3508549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection.
    Bondesson U; Lindström LH
    Psychopharmacology (Berl); 1988; 95(4):472-5. PubMed ID: 3145517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.
    Balant-Gorgia AE; Balant L
    Clin Pharmacokinet; 1987 Aug; 13(2):65-90. PubMed ID: 2887326
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.
    Fitton A; Heel RC
    Drugs; 1990 Nov; 40(5):722-47. PubMed ID: 2292234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.